Meiji Yasuda Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-374
| Closed | -$253K | – | 564 |
|
|
2025
Q4 | $253K | Sell |
374
-75
| -17% | -$51.1K | 0.01% | 473 |
|
|
2025
Q3 | $287K | Sell |
449
-35
| -7% | -$21.2K | 0.01% | 437 |
|
|
2025
Q2 | $260K | Sell |
484
-735
| -60% | -$351K | 0.01% | 453 |
|
|
2025
Q1 | $512K | Buy |
1,219
+74
| +6% | +$32.1K | 0.02% | 428 |
|
|
2024
Q4 | $473K | Sell |
1,145
-99
| -8% | -$43.4K | 0.02% | 447 |
|
|
2024
Q3 | $628K | Buy |
1,244
+28
| +2% | +$13.6K | 0.02% | 392 |
|
|
2024
Q2 | $592K | Sell |
1,216
-239
| -16% | -$120K | 0.02% | 392 |
|
|
2024
Q1 | $786K | Buy |
1,455
+220
| +18% | +$120K | 0.03% | 336 |
|
|
2023
Q4 | $685K | Sell |
1,235
-66
| -5% | -$31K | 0.03% | 352 |
|
|
2023
Q3 | $569K | Buy |
1,301
+106
| +9% | +$52.9K | 0.03% | 410 |
|
|
2023
Q2 | $600K | Sell |
1,195
-10
| -0.8% | -$4.79K | 0.03% | 367 |
|
|
2023
Q1 | $603K | Buy |
1,205
+340
| +39% | +$163K | 0.03% | 366 |
|
|
2022
Q4 | $353 | Hold |
865
| – | – | 0.02% | 491 |
|
|
2022
Q3 | $282K | Sell |
865
-151
| -15% | -$55.5K | 0.02% | 519 |
|
|
2022
Q2 | $356K | Sell |
1,016
-3
| -0.3% | -$1.22K | 0.02% | 498 |
|
|
2022
Q1 | $557K | Sell |
1,019
-173
| -15% | -$91K | 0.03% | 434 |
|
|
2021
Q4 | $785K | Buy |
1,192
+98
| +9% | +$61.5K | 0.05% | 309 |
|
|
2021
Q3 | $680K | Buy |
1,094
+81
| +8% | +$54.4K | 0.05% | 319 |
|
|
2021
Q2 | $640K | Buy |
1,013
+60
| +6% | +$33.1K | 0.03% | 332 |
|
|
2021
Q1 | $466K | Sell |
953
-482
| -34% | -$241K | 0.03% | 359 |
|
|
2020
Q4 | $717K | Buy |
1,435
+95
| +7% | +$42.5K | 0.07% | 237 |
|
|
2020
Q3 | $527K | Sell |
1,340
-640
| -32% | -$237K | 0.06% | 251 |
|
|
2020
Q2 | $654K | Buy |
1,980
+590
| +42% | +$171K | 0.06% | 255 |
|
|
2020
Q1 | $337K | Sell |
1,390
-780
| -36% | -$204K | 0.06% | 217 |
|
|
2019
Q4 | $567K | Hold |
2,170
| – | – | 0.05% | 315 |
|
|
2019
Q3 | $590K | Hold |
2,170
| – | – | 0.05% | 334 |
|
|
2019
Q2 | $597K | Buy |
2,170
+160
| +8% | +$39.4K | 0.05% | 337 |
|
|
2019
Q1 | $449K | Hold |
2,010
| – | – | 0.04% | 377 |
|
|
2018
Q4 | $374K | Buy |
2,010
+850
| +73% | +$174K | 0.03% | 394 |
|
|
2018
Q3 | $290K | Hold |
1,160
| – | – | 0.02% | 435 |
|
|
2018
Q2 | $253K | Hold |
1,160
| – | – | 0.02% | 448 |
|
|
2018
Q1 | $222K | Buy |
+1,160
| New | +$214K | 0.02% | 463 |
|
Other funds holding IDXX
Meiji Yasuda Asset Management's IDXX Position: Q1 2026 in Review
Meiji Yasuda Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 374 shares — an estimated $253K sold.
Meiji Yasuda Asset Management first reported a position in IDXX in Q1 2018 and held it in 32 quarters. The position peaked at $786K in Q1 2024. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Meiji Yasuda Asset Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Meiji Yasuda Asset Management sold 374 Idexx Laboratories shares in Q1 2026, an estimated $253K.
- Meiji Yasuda Asset Management first reported a position in Idexx Laboratories in Q1 2018 and held it in 32 quarters.
- Meiji Yasuda Asset Management's Idexx Laboratories position peaked at $786K in Q1 2024.
- 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Meiji Yasuda Asset Management's 13F filing for Q1 2026, filed 14 May 2026.